Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Donatella Delle Cave

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4019-2778; OpenAlex author ID A5058804707. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 4 papers · 2025: 1 paper · 2026: 2 papers

Papers 11

  1. Liquid biopsy in pancreatic cancer: current advances, limitations, and future perspectives. Co-author DOI 10.1016/j.dld.2026.03.002↗
  2. Special Issue "Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition". Last author DOI 10.3390/ijms27198735↗
  3. TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and … Co-author DOI 10.1038/s41419-025-07859-8↗
  4. A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening. Co-author DOI 10.1002/adhm.202401138↗
  5. Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism. Co-author DOI 10.1186/s13046-024-03072-1↗
  6. Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives. Last author DOI 10.3390/ijms25031631↗
  7. Emerging Therapeutic Options in Pancreatic Cancer Management. Co-author DOI 10.3390/ijms25031929↗
  8. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. Co-author DOI 10.1186/s13046-022-02516-w↗
  9. The Revolutionary Roads to Study Cell-Cell Interactions in 3D In Vitro Pancreatic Cancer Models. Co-author DOI 10.3390/cancers13040930↗
  10. TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation. Co-author DOI 10.1038/s41388-020-1289-1↗
  11. A synergic approach to enhance long-term culture and manipulation of MiaPaCa-2 pancreatic cancer spheroids. First author DOI 10.1038/s41598-020-66908-8↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Enza Lonardo · 7 shared papers, 2020–2025 · strength 1.11
  2. Bruno Sáinz · 4 shared papers, 2021–2025 · strength 0.65
  3. Loretta L. del Mercato · 3 shared papers, 2020–2024 · strength 0.51
  4. Claudia Vilardo · 1 shared paper, 2026 · strength 0.50
  5. Gabriella Minchiotti · 2 shared papers, 2024–2025 · strength 0.37
  6. Christos Adamopoulos · 1 shared paper, 2024 · strength 0.36
  7. Athanasios G. Papavassiliou · 1 shared paper, 2024 · strength 0.36
  8. Silvia Carrara · 1 shared paper, 2026 · strength 0.36
  9. Claudio Luchini · 1 shared paper, 2026 · strength 0.36
  10. Iréne Esposito · 1 shared paper, 2026 · strength 0.36
  11. Manuel Gentiluomo · 1 shared paper, 2026 · strength 0.36
  12. Alessandro Carrer · 2 shared papers, 2022–2025 · strength 0.31
  13. Christopher Heeschen · 2 shared papers, 2020–2022 · strength 0.23
  14. Stefania Forciniti · 1 shared paper, 2024 · strength 0.22
  15. Anna Chiara Siciliano · 1 shared paper, 2024 · strength 0.22
  16. Cristina D’Aniello · 1 shared paper, 2024 · strength 0.17
  17. Eduardo Ibello · 1 shared paper, 2024 · strength 0.17
  18. Marta Cavo · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.